I don't mind the strategy but feel overpaying especially if it is ongoing fro the life of their introduced customer.
I am sure NXS would say oh but they will be liaising with the surgeons and keeping them on board and maybe to a small degree but if the product is good will sell repeatedly and then NXS just need product and relationship managers.
Then again it could be a masterstroke to really get the sales team pushing it aggressively and expanding it to levels never before soon, and fast.
Ann: 2021 AGM Presentation, page-18
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $59.89M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $5.695K | 28.30K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 154395 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 5955 | 2 |
View Market Depth
| Last trade - 12.22pm 29/08/2024 (20 minute delay) ? |
| NXS (ASX) Chart |